Financial News · Live Terminal

Page 8 of 682

Mizuho Securities Adjusts Albemarle Price Target to $140 From $160, Maintains Neutral Rating

Albemarle (ALB) has an average rating of overweight and mean price target of $176, according to analysts polled by FactSet.Price: $110.77, Change: $-4.28, Percent Change: -3.72%

$ALB

Wire3d ago

Walt Disney Names Karandeep Anand as Chief Technology Officer

Walt Disney (DIS) said Friday that Karandeep Anand has been named senior executive vice president and chief technology officer, a newly created position, effective Oct. 2.Anand most recently served as chief executive of Character.AI, and will report directly to Disney CEO Josh D'Amaro, the company said.Price: $103.28, Change: $-2.07, Percent Change: -1.96%

$DIS

Wire3d ago

Salesforce's AIforce Offering has Potential to Drive Usage but Price Point is Too High, UBS Says

Salesforce's (CRM) new AIforce offering has the potential to drive usage, but its price point is too high to drive material near-term traction, UBS Securities said in a note emailed Friday, following the company's big Dreamforce conference in San Fransisco.UBS said it remains constructive on Salesforce's initiatives to improve higher core CRM usage by integrating AI models as new front-end interfaces. This "headless" model seems inevitable, as other firms will follow suit, and anything that improves the customer user experience is a net positive, the firm added. However, the monetization plan keeps the brokerage cautious, according to the note.The firm said it will be difficult to motivate budget-constrained customers to upgrade to the AIforce Max SKU at $550 per seat per month or to buy a new $65 to $75 seat bundle, in addition to paying the large language model provider.UBS and other investors were not expecting Salesforce to raise the fiscal 2030 revenue target of $63 billion, and the company did not, as it requires a 3-year compound annual growth rate of nearly 10.5%. The company sounded very positive on new bookings and the stock keeping unit upgrade trends, the note added.The brokerage lowered its fiscal 2028 revenue growth estimate, as it now believes the path to fiscal 2030 will not be linear and will be more weighted toward fiscal 2029 and 2030, according to the note.UBS kept a neutral rating on Salesforce and raised its price target to $260 from $240.Price: $240.13, Change: $-2.72, Percent Change: -1.12%

$CRM

Wire3d ago

Apple's iPhone 18 Pro Wait Times Shorten, Signaling Muted Demand, UBS Says

Apple (AAPL) faces softer early demand for its new iPhone 18 Pro and Pro Max based on shorter wait times since preorders opened on Saturday, UBS Securities said Thursday in a report.Using comparisons from a year earlier across 30 countries, UBS found that average wait times are about two days shorter at 16 days for the iPhone 18 Pro and 23 days for the Pro Max.Pro Max wait times were little changed in the UK and Japan and four days shorter in China, UBS said. For the Pro model, the US was the only region showing longer wait times by one day, while China's wait times were 10 days shorter, the report said.China's data may be affected by customers holding off purchases ahead of Apple's Duo foldable phone, which launches next month, UBS said.The muted early wait times likely reflect strong demand for last year's iPhone 17 lineup, incremental changes in the new models, and higher average selling prices, the report said.UBS has a neutral rating on Apple stock with a $296 price target.Price: $334.60, Change: $-2.40, Percent Change: -0.71%

$AAPL

Wire3d ago

FTC Solar Turnaround Likely Underway, UBS Says

FTC Solar's (FTCI) revamped product portfolio and recent orders support expectations for a strong revenue growth, with adjusted EBITDA set to be positive in 2028, UBS said in a note Friday.The report said recent US and Australian orders and shipments start for the Fraser Coast project suggest that its revamped 1P and First Solar-compatible trackers are gaining acceptance.UBS analysts expect a 40% revenue growth in 2026 and a 45% compound annual growth rate from 2027 to 2030, which should help the firm reach positive adjusted EBITDA in 2028.But the share price appears to imply only about $5 million of EBITDA in 2028, nearly 50% below UBS estimate, they said."The depressed valuation underestimates the earnings power of the company's product-driven turnaround," the analysts said.UBS upgraded the stock to buy from neutral and raised its price target to $3.60 from $3.50.Price: $2.49, Change: $+0.36, Percent Change: +16.90%

$FTCI

Wire3d ago

Vail Resorts' Epic Pass Sales Decelerate, Raising Fiscal 2027 Concerns, UBS Says

Vail Resorts' (MTN) Epic Pass sales appear to have decelerated into September, raising concerns over demand trends and the company's ability to meet fiscal 2027 consensus expectations, UBS Securities said in a Friday note.The investment firm said its checks and Epic sales transaction data indicate a low- to mid-single digit pass sales decline season-to-date compared with trends as of the end of May. Pass sales are considered a "key driver of forward visibility" for Vail Resorts.With the projected deceleration in pass sales, the company would need a significant increase in lift business to meet fiscal 2027 consensus. The investment firm estimates that lift sales would have to grow more than mid teens to raise overall sales to a "flattish" level.Mix shift could buoy overall sales, with higher lift business versus a slight fall in pass sales, according to the note.UBS has a neutral rating on Vail Resorts, with a $139 price target.Shares of Vail Resorts were up 1.6% in Friday afternoon trading.Price: $139.95, Change: $+2.19, Percent Change: +1.59%

$MTN

Wire3d ago

Truist Securities Adjusts ON Semiconductor Price Target to $75 From $91, Maintains Hold Rating

$ON

Wire3d ago

Amer Sports' Salomon Faces Solid Long-Term Growth Opportunities, UBS Securities Says

Amer Sports' (AS) investor day reinforced the thesis that its Salomon brand's "technical authenticity, sportstyle momentum, and category expansion" will lead to a path of at least mid-teens percentage sales growth, UBS Securities said in a note Friday.The investment firm said that Salomon, along with Amer's "disciplined investments" in Arc'teryx and Wilson Tennis 360, should support the company's growth momentum throughout its five-year plan and beyond.Analysts said Amer is still "one of the best growth stocks in Softlines" and the stock will likely outperform backed by stronger-than-expected growth over the next 12 months.The firm said it sees upside to Amer's long-term earnings per share guidance, citing the company's multiyear investments across its brands and management's inclination to issue beatable guidance.UBS Securities maintained its buy rating on Amer and $62 price target.Price: $26.91, Change: $+0.64, Percent Change: +2.42%

$AS

Wire3d ago

Brinker's Unit Expansion, Remodels Could Sustain Sales Growth, UBS Says

Brinker International's (EAT) plan to open and remodel more Chili's restaurants could help sustain sales growth and lift margins, UBS Securities said in a report Friday, following the company's investor day.Brinker set three-year targets for annual revenue growth of 4% to 6%, restaurant growth of 2% to 3% by 2029 and double-digit earnings-per-share growth, the firm noted. The company could exceed those targets as menu improvements, value offerings, marketing and operational enhancements support customer traffic, the report said.The firm called the restaurant growth target as "likely achievable," citing "attractive unit economics" and room to expand across the US. Brinker also plans to remodel 60 to 80 Chili's restaurants in fiscal 2027, the firm noted, adding that the 16 remodels to date have produced "sales lift" of about 3% to 5%.Brinker plans to prioritize new restaurants and remodels while maintaining a "strong balance sheet" and repurchasing shares. Its buyback goal is to reduce its share count by about 3% to 5% annually, the report said."We believe further upside potential exists for shares from the sustainability of sales outperformance and potential for better than expected earnings in FY27 & beyond," UBS said.UBS has a buy rating on Brinker with a price target of $285 per share.Price: $193.03, Change: $-6.54, Percent Change: -3.27%

$EAT

Wire3d ago

Corpay to Pay $100 Million to Resolve FTC Allegations

Corpay (CPAY) said Friday it has agreed to pay the US Federal Trade Commission $100 million to settle previously disclosed marketing and disclosure allegations regarding its domestic vehicle payments unit.The proposed resolution involves no admission of wrongdoing and imposes no personal financial penalty on the CEO, while maintaining a June 2023 federal court order, the company said.Management expects no material impact on ongoing financial results from the agreement, which awaits final regulatory approval following a public comment period, Corpay said.Price: $398.87, Change: $-5.39, Percent Change: -1.33%

$CPAY

Wire3d ago

Orion180 Insurance Shares Fall in Nasdaq Debut

Orion180 Insurance (OIG) shares fell 4.2% to $11.50 in their Nasdaq debut on Friday.The home- and flood-insurer priced an IPO of 20 million class A common shares at $12 each, for a $240 million equity raise before expenses.The offering is set to close on Monday.Price: $11.50, Change: $-0.50, Percent Change: -4.17%

$OIG

Wire3d ago

Arrive AI Details DXC Partnership to Deploy Autonomous Delivery in Manufacturing

Arrive AI (ARAI) on Friday offered additional details of its previously disclosed partnership with DXC Technology (DXC) to deploy its Arrive Point autonomous delivery infrastructure in manufacturing campuses.DXC's systems integration know-how will help connect Arrive AI's technology into the IT systems operating within enterprise-scale manufacturing facilities, the company said.Arrive AI's platform enables drones, ground robots, autonomous vehicles, and human couriers to exchange goods through the same delivery point, eliminating the need for a person to be present during drop-offs and pickups, according to a statement.Price: $0.26, Change: $+0.01, Percent Change: +5.28%

$ARAI$DXC

Wire3d ago

O'Reilly Automotive's Competitive Advantage a Combination of Culture, Supply Chain, Strategy, UBS Says

O'Reilly Automotive's (ORLY) competitive advantage stems from its deeply ingrained culture, sophisticated supply chain, and management team that focuses on long-term market share gains over short-term optimization, UBS said in a note.The company continues to promote from within, viewing continuity as a strategic asset. The company has also selectively added outside talent when modernization efforts required new expertise, UBS said on Thursday.The company's highly sophisticated supply chain remains O'Reilly Automotive's "competitive weapon," UBS said, adding that the company's inventory is tailored to local vehicle populations, repair patterns, and customer demand characteristics.Additionally, the company's dual-market strategy catering to both do-it-yourself customers and professional customers remains central to the company's investment thesis, according to the note.UBS maintained its buy rating with a $120 price target.Price: $84.51, Change: $-0.38, Percent Change: -0.45%

$ORLY

Wire3d ago

Lennox Keeps Quarterly Cash Dividend at $1.36 a Share, Payable Oct. 15 to Holders of Record Sept. 30

$LII

Wire3d ago

Biohaven's Kv7 Program Remains Key Stock Driver, UBS Says

Biohaven's (BHVN) stock performance is likely to remain focused on the outlook for its Kv7 program as the company navigates regulatory uncertainty around BHV-7000, while upcoming obesity data in H2 is expected to be a secondary catalyst, UBS Securities said in a note.The firm said the largest potential driver of stock upside is Biohaven's degrader program in generalized dystonia and IgA nephropathy.UBS remains confident the degraders could differentiate from competition, but noted that the primary completion dates are January 2028 for generalized dystonia and September 2028 for IgA nephropathy.The firm also noted Biohaven's partial clinical hold on BHV-7000 requires additional nonclinical studies related to a metabolite observed in rodents and pauses enrollment in the RISE-2 study. The partial hold does not affect RISE-3, which is fully enrolled, with UBS expecting data in November.UBS reiterated its neutral rating and $11 price target on Biohaven.Price: $13.99, Change: $+0.10, Percent Change: +0.72%

$BHVN

Wire3d ago

Element Solutions Offers Attractive Risk-Reward Amid Strong Electronics Demand, UBS Says

Element Solutions' (ESI) strong electronics demand and improving growth profile create an attractive risk-reward setup for the stock, UBS Securities said.The brokerage said in a Thursday note that the stock started to re-rate through H1, supported by catalysts like two higher growth acquisitions around electronics and the divestment of slower growth graphics.The company's earnings setup for 2026 is beatable, and the 2027 consensus could be conservative if robust electronics trends continue, according to the note.The company's risk/reward skew is attractive at current levels, analysts wrote, adding that they expect adjusted EPS compound annual growth rate of around 17%.UBS reiterated its buy rating on the stock and adjusted its price target to $47 per share from $49.Price: $33.28, Change: $+0.12, Percent Change: +0.36%

$ESI

Wire3d ago

Update: Uber Technologies Ordered to Pay $40 Million in California Wrongful Death Case

(Updates with Uber's response in the third paragraph.)Uber Technologies (UBER) was ordered to pay $40 million to the parents of Emily Normandin-Parker who was struck and killed along a California freeway in August 2023 after her Uber driver pulled over, law firm Panish Shea Ravipudi said Thursday.Following a five-day arbitration, a retired judge found that Uber functions as a common carrier with a non-delegable duty to protect passengers and that it is liable for the negligence of its driver, according to the resolution.In a statement emailed to, a Uber spokesperson said the company expressed sympathy to the Normandin-Parker family, but disputed the arbitrator's liability finding and said it has continued strengthening safety measures, including guidance to drivers on avoiding unsafe drop-off locations.Uber shares were down 0.6% in Friday trading.Price: $70.50, Change: $-0.37, Percent Change: -0.52%

$UBER

Wire3d ago

HSBC Reports 'Enhanced' US Premier Offering

HSBC (HSBC) reported Friday an "enhanced" Premier offering in the US to meet the needs of its customers.The offering spans wealth, health, travel and international as it expands its focus on serving "affluent" consumers, the firm said.Price: $101.36, Change: $-1.48, Percent Change: -1.44%

$HSBC

Wire3d ago

Axsome's Auvelity Launch Shows Early Strength in Alzheimer's Agitation, RBC Says

Axsome Therapeutics' (AXSM) investors remain focused on the launch of Auvelity for Alzheimer's agitation, RBC Capital Markets said Friday in a report.Early signs from the launch are encouraging, and Auvelity is on track to meet RBC's $804 million fiscal 2026 sales estimate and exceed Wall Street expectations, the 26-page report said.RBC's survey of 77 physicians, representing about 2,600 patients, found doctors like Auvelity's profile, expect to increase use, and are seeing steady patient growth.Physicians estimated that about one-third of their Alzheimer's agitation patients also have depression, which often leads doctors to start patients on Auvelity's full dose rather than the starter pack, a pattern that helps lift paid prescriptions and revenue, the report said.RBC maintained its outperform rating on Axsome and its $297 price target.Price: $210.42, Change: $-3.86, Percent Change: -1.80%

$AXSM

Wire3d ago

Array Technologies Has Less Flexibility to Expand Offering, Defend Competitive Position, UBS Says

Array Technologies (ARRY) likely has less flexibility to expand its product offering and defend its competitive position as it transitions its preferred dividend payment method to cash from payment-in-kind, UBS Securities said in a note Friday.Analysts said the transition changes the outlook for free cash flow deployment.While the company is expected to generate sufficient free cash flow to cover the preferred dividend, the transition reduces cash available for deleveraging and growth, particularly through mergers and acquisitions, according to the note.Analysts said, however, that they have a positive view on the direction of the US solar industry, particularly for companies with domestic manufacturing footprints like Array.UBS downgraded the stock to neutral from buy, and lowered its price target to $5 from $10.Shares of Array Technologies were down 8.3% in Friday trading.Price: $3.89, Change: $-0.35, Percent Change: -8.25%

$ARRY

Showing 141-160 of 13627